Brief: Entero Therapeutics Terminated Interim CEO And Chairman Richard Joel Paolone Effective Immediately - SEC Filing
09/09/2025 22:05
Sept 9 (Reuters) - Entero Therapeutics Inc ENTO.O: ENTERO THERAPEUTICS INC - ON SEPT 3 TERMINATED INTERIM CEO AND CHAIRMAN RICHARD JOEL PAOLONE EFFECTIVE IMMEDIATELY - SEC FILING ENTERO THERAPEUTICS INC - ON SPET 4 APPOINTED JASON D. SAWYER AS INTERIM CEO - SEC FILING ENTERO THERAPEUTICS INC - PAOLONE REMAINS DIRECTOR AFTER TERMINATION AS CEO - SEC FILING Source text: [ID:n0001104659-25-088663] Further company coverage: ENTO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on GridAI Technologies
See all newsBrief: Gridai Technologies Corp - Enters $2.54 Million Private Placement Of Shares And Warrants - SEC Filing
Brief: IBN Announces Latest Episode Of The Techmediawire Podcast Featuring Marshall Chapin, CEO Of Grid Ai Corp.
Brief: Entero Therapeutics Terminated Interim CEO And Chairman Richard Joel Paolone Effective Immediately - SEC Filing
Brief: Entero Therapeutics Inc - Now Offering 15.2 Million Shares Of Common Stock
Brief: Entero Therapeutics Inc Subsidiary Immunogenx Enters Settlement Agreement